Mr Sajal Saha

Antimicrobial Stewardship Pharmacist Mentor

Qualifications:

PhD (Award is due), Monash University, 2021; Master of Public Health, University of Leeds, 2016; Master of Clinical Pharmacy and Pharmacology, University of Dhaka, 2008; Bachelor of Pharmacy, University of Dhaka, 2007

Approved level of HDR supervision at Charles Darwin University:

Academic level B

Location:

Timor-Leste

Biography:

Mr Sajal Saha is by training an academic pharmacist and a commonwealth scholar. He is a PhD fellow of the Australian National Centre for Antimicrobial Stewardship and on track to complete his PhD in antimicrobial stewardship from Monash University.

Saha’s research has developed a General Practitioner-pharmacist collaborative antimicrobial stewardship (GPPAS) model that guides how to improve antimicrobial stewardship in Australian primary care by fostering GP-pharmacist collaboration. His research unveils the role of pharmacists in the prudent use of antimicrobials in response to the global problem of antimicrobial resistance.

Saha has been actively involved in pharmacy teaching and research since 2009. He has successfully supervised six master student’s thesis projects as a primary supervisor.

He has published 36 peer-reviewed articles with recognised publishers including BMJ, Oxford University Press, Cambridge University Press, Elsevier, and MDPI, and has presented in over 20 international conferences held in the USA, Canada, UK, France, Switzerland, Australia and Bangladesh. Saha also works as a reviewer for 10 medical and pharmacy journals.

His academic achievements have been reflected through the Monash Research Impact Award 2020, AAAPC Travelling Fellowship 2021, Pan Canadian TUTOR-PHC Trainee Stipend Award 2020, UK Commonwealth Scholarship 2015, Best Teacher Award 2010 and Deans Award 2007.

  1. Saha, S. K., Kong, D. C., Thursky, K., & Mazza, D. (2021). Development of an antimicrobial stewardship implementation model involving collaboration between general practitioners and pharmacists: GPPAS study in Australian primary care. Primary Health Care Research & Development, 22.
  2. Saha, S. K., Kong, D., Thursky, K., & Mazza, D. (2021). Divergent and Convergent Attitudes and Views of General Practitioners and Community Pharmacists to Collaboratively Implement Antimicrobial Stewardship Programs in Australia: A Nationwide Study. Antibiotics, 10(1), 47.
  3. Saha, S. K., Kong, D. C., Thursky, K., & Mazza, D. (2020). Antimicrobial stewardship by Australian community pharmacists: Uptake, collaboration, challenges, and needs. Journal of the American Pharmacists Association.
  4. Saha, S. K., Kong, D., Thursky, K., & Mazza, D. (2020). A nationwide survey of Australian general practitioners on antimicrobial stewardship: Awareness, uptake, collaboration with pharmacists and improvement strategies. Antibiotics, 9(6), 310.
  5. Buckingham, P., Amos, N., Saha, S. K., Hussainy, S. Y., & Mazza, D. (2020). Contraception decision aids to improve care and effective method use. Cochrane Database of Systematic Reviews, 2020(7), CD013659.
  6. Promite, S., & Saha, S. K. (2020). Escherichia coli in respiratory tract infections: Evaluating antimicrobial resistance and prevalence of fimA, neuC and iutA virulence genes. Gene Reports, 18, 100576.
  7. Saha, S. K., Barton, C., Promite, S., & Mazza, D. (2019). Knowledge, perceptions and practices of community pharmacists towards antimicrobial stewardship: A systematic scoping review. Antibiotics, 8(4), 263.
  8. Saha, S. K., Hawes, L., & Mazza, D. (2019). Effectiveness of interventions involving pharmacists on antibiotic prescribing by general practitioners: A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy, 74(5), 1173-1181.
  9. Saha, S. K., Hawes, L., & Mazza, D. (2018). Improving antibiotic prescribing by general practitioners: a protocol for a systematic review of interventions involving pharmacists. BMJ open, 8(4).
  10. Saha, S. K., Das, S. C., Abdullah-Al-Emran, Sarker, M., Uddin, M. A., Chowdhury, A. A., & Bachar, S. C. (2013). Biochemical alterations and liver toxicity analysis with pioglitazone in healthy subjects. Drug and chemical toxicology, 36(2), 149-154.